SEC Form 4
Lipocine Inc. (LPCN) insider trading
In the 12 months to Oct 26, 2026, 2 LPCN insiders reported open-market purchases of $516.8K across 6 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $516.8K
- 6 filings
Who traded LPCN, and when
- Purchase
LPCN daily close from Oct 27, 2025 to Oct 26, 2026, between $1.42 and $11.26, last $1.42. 0 sale and 6 purchase filings by 2 insiders, marked at their filing dates. John W. Higuchi, Director: bought $415.5K across 4 filings, first filed Apr 6, 2026, last Oct 1, 2026. Mahesh V. Patel, Chief Executive Officer: bought $101.3K across 2 filings, first filed Apr 2, 2026, last Apr 6, 2026.
Largest mark · tap a row for others
John W. Higuchi · Director
Filing 1 of 2 within a week · $333,350 total
Purchase $252,150
123,000 shares at $2.05 avg
Filed Apr 6, 2026
Close on filing date $1.94
John W. Higuchi · Director
Director
$415.5K boughtMahesh V. Patel · Chief Executive Officer
Chief Executive Officer
$101.3K boughtOpen-market trades
6 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| John W. Higuchi | Director | — | $415.5K | 4 | — | |
| Mahesh V. Patel | Chief Executive Officer | — | $101.3K | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | John W. Higuchi Director | Purchase | 25,007 | $2.20 | $55.0K | 241,365 | |
traded | John W. Higuchi Director | Purchase | 12,561 | $2.16 | $27.1K | 216,358 | |
traded | John W. Higuchi Director | Purchase | 40,000 | $2.03 | $81.2K | 203,797 | |
traded | Mahesh V. Patel Chief Executive Officer | Purchase | 25,000 | $2.03 | $50.7K | 160,679 | |
traded | John W. Higuchi Director | Purchase | 123,000 | $2.05 | $252.1K | 163,797 | |
traded | Mahesh V. Patel Chief Executive Officer | Purchase | 25,000 | $2.02 | $50.5K | 135,679 |
GET /stocks/filings/vX/form-4?tickers=LPCN&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"LPCN"
],
"issuer_cik": "0001535955",
"owner_cik": "0001579891",
"accession_number": "0001493152-26-045400",
"form_type": "4",
"filing_date": "2026-10-01",
"period_of_report": "2026-09-29",
"issuer_name": "Lipocine Inc.",
"issuer_trading_symbol": "LPCN",
"owner_name": "Higuchi John W.",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-29",
"deemed_execution_date": "2026-09-29",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 9037,
"transaction_price_per_share": 2.15,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 225395,
"transaction_value": 19429.55,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"LPCN"
],
"issuer_cik": "0001535955",
"owner_cik": "0001579891",
"accession_number": "0001493152-26-045400",
"form_type": "4",
"filing_date": "2026-10-01",
"period_of_report": "2026-09-29",
"issuer_name": "Lipocine Inc.",
"issuer_trading_symbol": "LPCN",
"owner_name": "Higuchi John W.",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-30",
"deemed_execution_date": "2026-09-30",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 15970,
"transaction_price_per_share": 2.23,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 241365,
"transaction_value": 35613.1,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Lipocine Inc.'s CEO sold stock?
No. Mahesh V. Patel (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is LPCN’s insider data?
These are LPCN Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track LPCN insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for LPCN every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.